Kintor Pharmaceutical completes patient enrollment in KX-826 phase 2 trial
Kintor Pharmaceutical said that it has wrapped up patient enrollment for the phase 2 clinical trial of KX-826 (pyrilutamide) in China for the treatment of ... Read More
Kintor Pharmaceutical gets EUA for Covid drug proxalutamide in Paraguay
Kintor Pharmaceutical has secured an emergency use authorization (EUA) for proxalutamide (GT-0918) for the treatment of hospitalized patients with Covid-19 infections in Paraguay. The EUA ... Read More